MARATTO

article · PubMed

[In vitro activity of ceftazidime- avibactam and ceftolozane- tazobactam against clinical isolates of enterobacteriaceae and <i>pseudomonas æruginosa</i>: results from a trauma center and burn unit in tunisia].

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

, CZA currently represents the most active β-lactam against CAZ-R strains and the second most active molecule overall, including those producing carbapenemases.

Research topics

  • Antibiotic Resistance in Bacteria
  • Enterobacteriaceae and Cronobacter Research
  • Escherichia coli research studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.